This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Questions about our CME?
Questions about our CME?
MediBrief: Fast-tracking Emerging Non-Small Cell Lung Cancer Immunotherapy Evidence into Practice

MediBrief: Fast-tracking Emerging Non-Small Cell Lung Cancer Immunotherapy Evidence into Practice

Format

Monograph

Time to Complete

1 hour

Released

June 28, 2018

Expires

June 28, 2019
Add to Queue


Maximum Credits

1.00 / AMA PRA Category 1 Credit(s)TM

Accredited Provider



This activity is provided by Global Education Group.

Commercial Supporter

This activity is supported by an educational grant from Genentech.

Program Description

MediBrief: Fast-tracking Emerging Non-Small Cell Lung Cancer (NSCLC) Immunotherapy Evidence into Practice is an educational activity that provides clinicians with ways to quickly act on key summarized interpretations and fair/balanced, evidence-based recommendations about issues pertaining to NSCLC immunotherapy. All information is prepared in brief, but concise and clinically accurate portions that are sensitive to the time constraints of busy clinicians. At the end of each brief summarized pearl, clinically accurate and relevant suggestions posed as short call-out examples are provided, as a means to bring suggested options to practice. Clinicians may digest and apply these suggestions to real-life practice for personalized NSCLC management.

Program Agenda

Pre-Test – 5 minutes
Abstracts – 45 minutes
Post-Test – 5 minutes
Evaluation – 5 minutes

Intended Audience

The educational design of this activity addresses the needs of US-based community oncologists and other healthcare professionals involved in the treatment of patients with NSCLC.

Educational Objectives

After completing this activity, the participant should be better able to:

  • Identify the use of biomarkers that may help select those patients most likely to benefit from current and emerging NSCLC targeted treatments and cancer immunotherapies
  • Discuss the advances made in NSCLC immunotherapy research that could impact targeted treatment decisions made by the inter-professional oncology team
  • Evaluate the clinical utility of lung cancer immunotherapy

Fee and Refund / Cancellation Policy

There is no fee for this educational activity.

Conflict Of Interest Disclosure Policy

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Accredited Provider Disclosure

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Chirag Bhagat, PharmD, has nothing to disclose.
Ashley Marostica, RN, MSN, has nothing to disclose.
Lindsay Borvansky has nothing to disclose.
Andrea Funk has nothing to disclose.
Liddy Knight has nothing to disclose.

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

Global Education Group designates this enduring activity for a maximum of 1.00 AMA PRA Category 1
Credit(s)
TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) does not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Instructions

To obtain credit, a post-test score of 70% or better is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test survey, and have received your digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can then access at any time.

For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

If you have any questions relating to other issues with this activity, please contact myCME.Support@haymarketmedical.com.

Privacy Policy

myCME privacy policy

Global protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. Global and our joint sponsors will not release personally identifiable information to a third party without the customer’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue